Dr. Barone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Rockland Rd
Wilmington, DE 19803Phone+1 302-651-4200
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Hematology/Oncology, 2010 - 2013
Sidney Kimmel Medical College at Thomas Jefferson University/Nemours Children's Health, WilmingtonResidency, Pediatrics, 2007 - 2010
University of Cincinnati College of MedicineClass of 2007
Certifications & Licensure
VA State Medical License 2022 - 2026
DE State Medical License 2014 - 2023
MO State Medical License 2010 - 2015
PA State Medical License 2007 - 2010- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 99 citationsPatients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis.Julia A. Beaver, Maitreyee Hazarika, Flora Mulkey, Sirisha Mushti, Huanyu Chen
The Lancet. Oncology. 2018-02-01 - 48 citationsFDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing RegimenAmy Barone, Dow-Chung Chi, Marc R. Theoret, Huanyu Chen, Kun He
Clinical Cancer Research. 2017-12-15 - 59 citationsFDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic MelanomaAmy Barone, Maitreyee Hazarika, Marc R. Theoret, Pallavi S. Mishra-Kalyani, Huanyu Chen
Clinical Cancer Research. 2017-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
